News

The FDA guidance provides that the highest allowed dose will be 12mg daily. Repros is currently conducting a Phase II study for the use of Proellex in severe

Three of the four molecules it has designed are potent inhibitors of both cyclooxygenase-2 (COX-2) and COX-1 enzymes. The fourth inhibits COX-2 but only weakly inhibits COX-1. Simulations

The company said that the new purification facility will expand its capacity to produce active pharmaceutical ingredients (APIs) for a growing number of diabetes drugs under development. The

According to the company, the milestone is the first functional micro-pump integration using MEMS standard process on Leti’s 200mm line. It is a result of FluMin3, which is

MD Anderson’s Moon Shots Program would help in reducing cancer deaths by targeting eight cancers with the support of several new research platforms that provide infrastructure, expertise and

ATAGI has recommended Bexsero (meningococcal group B vaccine [rDNA, component, adsorbed]) for all young Australians, with an emphasis on infants and children under two years of age and

As part of the deal, Tesaro will receive rights to monospecific antibody drug candidates targeting TIM-3, LAG-3 and PD-1 and dual reactive antibody drug candidates targeting PD-1/TIM-3 and

SmartFactory is a single-use cGMP bio-manufacturing capacity, which will help Alvotech to rapidly expand its biosimilars business. Finesse’s customers will also have access to Alvogen’s commercial, FDA approved,

The company plans to submit a protocol to the US Food and Drug Administration (FDA) in the first half of 2014 for a Phase I/II clinical trial to